Gain Therapeutics Announces Positive Topline Results from the Phase 1[...]
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global[...]
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
08/29/2024 | Press release | Distributed by Public on 08/29/2024 04:03
Please select the service you want to use:
Smartlinks | Reconnaissance Energy (Africa) Ltd. | News | Environment | Conservation | Natural Resources | Finance | Energy Markets | Security Markets | Commodities | Security Markets | Company News | Top Company News | Energy Markets | Oil and Gas | Oil and Gas Upstream Activities | Securities Issuers | Oil and Gas Exploration and Production Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | TSX Venture Exchange | Cboe Canada | Omega ATS | Lynx ATS | CSE Pure Trading | Nasdaq CX2 | Nasdaq CXC | TSX Alpha Exchange
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact